-
Product Insights
NewLikelihood of Approval Analysis for Female Contraception
Overview How likely is it that the drugs in Female Contraception will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Female Contraception Overview Contraception (birth control) prevents pregnancy by interfering with the...
-
Sector Analysis
NewUnited Kingdom (UK) Easter Market Analysis, Trends, Consumer Attitudes and Buying Dynamics, 2024 Update
The UK Easter 2024 report forms part of GlobalData's Retail Occasions series, and offers a comprehensive insight into the consumer dynamics and spending habits of UK consumers for Easter. The report analyses the major players, the main trends, and consumer attitudes. The proportion of consumers that stated that they bought something for Easter fell in 2024 , as fewer consumers chose to spend on the event. The proportion of Easter shoppers purchasing food & drink held up better than other...
-
Sector Analysis
NewUnited Kingdom (UK) Easter Intentions and Consumer Spending Preferences, 2024 Update
The GlobalData Retail Easter intentions 2024 report forms part of the Retail Occasions series, and offers a comprehensive overview of the retail occasion of Easter, analysing consumers intentions for spending, gifting and celebrating.
-
Product Insights
NewLikelihood of Approval Analysis for Food Allergy
Overview How likely is it that the drugs in Food Allergy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Food Allergy Overview Food allergies are immune system reactions to certain proteins...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Omalizumab in Food Allergy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Omalizumab in Food Allergy Drug Details: Omalizumab (Xolair, Bolstran) is a recombinant DNA-derived humanized IgG1-kappa...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Omalizumab in Peanut Allergy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Omalizumab in Peanut Allergy Drug Details: Omalizumab (Xolair, Bolstran) is a recombinant DNA-derived humanized IgG1-kappa...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Omalizumab in Milk Allergy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Omalizumab in Milk Allergy Drug Details: Omalizumab (Xolair, Bolstran) is a recombinant DNA-derived humanized IgG1-kappa...
-
Sector Analysis
Female Sterilization Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Female Sterilization Devices Market Report Overview The female sterilization devices market was valued at $40 million in 2023 and is forecast to grow at a CAGR of more than 2% during 2023 and 2033. Female sterilization is a permanent procedure where the fallopian tubes are blocked using surgical and non-surgical techniques. The fallopian tubes are blocked to prevent the sperm from fertilizing the egg, thereby preventing the woman from becoming pregnant. This model covers female sterilization devices used in laparoscopic sterilization....
-
Product Insights
Focal Segmental Glomerulosclerosis (FSGS) – Drugs In Development, 2023
Global Markets Direct’s, ‘Focal Segmental Glomerulosclerosis (FSGS) - Drugs In Development, 2023’, provides an overview of the Focal Segmental Glomerulosclerosis (FSGS) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Focal Segmental Glomerulosclerosis (FSGS), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...